Torigen Pharmaceuticals


Torigen Pharmaceuticals is focused on veterinary cancer care. Their product, VetiVax, is a revolutionary cancer immunotherapy that uses the patient's own tumor cells to create a personalized treatment that educates the immune system to recognize the tumor as foreign.

Employees

11-50

Links


Org chart

Collapse
Mark Suckow
Chief Technology Officer
Troy Gobbett, PMP
Vice President of Operational Excellence
Mike Vaughn
Business Development Manager
Jon Wetzel
Business Development Manager
Chelsea Greenberg
Vice President of Veterinary Affairs


Offices